Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
21
self-reported 11–50 band
Founded
2015
11 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
4
Series A · Feb 2023 · US$ 5.7M
Company type
Privately Held
self-reported
Description
Design, development & commercialisation of animal-free aptamers for life science applications. Our mission is to replace animal-derived antibodies with aptamers. In Oct-2024, we launched the world's first aptamer-based histochemistry staining kit for HPV detection.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | MY |
All codes: MY
Addresses
- MYInfrastructure University Kuala Lumpur; Putrajaya, Selangor 43000Primary
Grid intelligence Members
Funding
Rounds4
Round typeSeries A · venture round
Amount (USD)5,700,000
Stage rank3
Investors named1
Since last round2 yr 11 mo
Funding
Show as table · 4 funding rounds
| Rounds | 4 |
|---|---|
| Axis | 2015 to 2026 |
| Series A · 18 Feb 2023 | US$ 5.7M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
FAQ
How many people work at Biogenes Technologies?
The record holds 21 counted staff profiles at January 2026, inside the self-reported 11–50 band.
Where does Biogenes Technologies have offices?
One address on record, Malaysia only. Primary: Infrastructure University Kuala Lumpur, Putrajaya, Selangor 43000.
Has Biogenes Technologies raised funding?
Four rounds. Latest 18 February 2023: Series A, US$5,700,000, investor Pembangunan Ekuiti.
Which companies are listed alongside Biogenes Technologies?
Eight peer profiles on record: SuperDNA and Duopharma Biotech Berhad.